APP and Alzheimer disease: In aged transgenic McGill-R-Thy1-APP rats expressing human APP751 with familial AD mutations, 5-week treatment with KG207-M markedly reduced brain Aβ levels measured by positron emission tomography reversed hippocampal atrophy and improved resting state functional connectivity [432].